Spanish Red Biotech Pipeline

MSD

Pembrolizumab/Lenvatinib/Belzutifan

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Pembrolizumab Plus Lenvatinib in combination with Belzutifan in solid tumors
Phase: 2Phase II in Spain, 1Phase I